GlobalData's clinical trial report, “Ataxia-Telangiectasia [Louis-Bar Syndrome] Global Clinical Trials Review, Q1, 2011" provides data on the Ataxia-Telangiectasia [Louis-Bar Syndrome] clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Ataxia-Telangiectasia [Louis-Bar Syndrome]. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top
five national contributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status and trial success rate- Review of key discontinued trials (suspended, withdrawn and terminated)- Overview of the enrollment pattern by phase for the past decade

Reasons to buy

- Understand the dynamics of a particular indication as a whole- Examine the performance of the trials in terms of their status, recruitment, success rates and others- Obtain discontinued trial information for trials across the globe- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
SHOW LESS
READ MORE >

PLEASE SELECT A FORMAT

Quick Help:
The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

EUR 1885USD 2,000GBP 1,325

SITE LICENSE Electronic (PDF)

Quick Help:
The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

EUR 2827USD 3,000GBP 1,987

ENTERPRISEWIDE Electronic (PDF)

Quick Help:
The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.